| For: | de Avelar CR, Pereira EM, de Farias Costa PR, de Jesus RP, de Oliveira LPM. Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis. World J Gastroenterol 2017; 23(27): 5004-5017 [PMID: 28785154 DOI: 10.3748/wjg.v23.i27.5004] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i27/5004.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, Ebtehal El-Demerdash. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Life Sciences 2021; 271 doi: 10.1016/j.lfs.2021.119220
|
| 3 |
|
| 4 |
Risha Ganguly, Ramesh Kumar, Abhay K Pandey. Baicalin provides protection against fluoxetine-induced hepatotoxicity by modulation of oxidative stress and inflammation. World Journal of Hepatology 2022; 14(4): 729-743 doi: 10.4254/wjh.v14.i4.729
|
| 5 |
Ana María García-Muñoz, Desirée Victoria-Montesinos, Pura Ballester, Begoña Cerdá, Pilar Zafrilla. A Descriptive Review of the Antioxidant Effects and Mechanisms of Action of Berberine and Silymarin. Molecules 2024; 29(19) doi: 10.3390/molecules29194576
|
| 6 |
Rocío Aller, Cristina Laserna, Miguel Ángel Rojo, Natalia Mora, Concepción García Sánchez, María Pina, Rebeca Sigüenza, Miguel Dur�, David Primo, Olatz Izaola, Daniel de Luis. Role of the PNPLA3 polymorphism rs738409 on silymarin + vitamin E response in subjects with non-alcoholic fatty liver disease. Revista Española de Enfermedades Digestivas 2018; 110 doi: 10.17235/reed.2018.5602/2018
|
| 7 |
Alessio Aghemo, Olga P. Alekseeva, Francesco Angelico, Igor G. Bakulin, Natalia V. Bakulina, Dmitry Bordin, Alexey O. Bueverov, Oxana M. Drapkina, Anton Gillessen, Elvira M. Kagarmanova, Natalia V. Korochanskaya, U. A. Kucheryavii, Leonid B. Lazebnik, Maria A. Livzan, Igor V. Maev, Anatolii I. Martynov, Marina F. Osipenko, Evgenii I. Sas, Antonina Starodubova, Yurii P. Uspensky, Elena V. Vinnitskaya, Emilia P. Yakovenko, Alexey A. Yakovlev. Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review. Annals of Medicine 2022; 54(1) doi: 10.1080/07853890.2022.2069854
|
| 8 |
Samira Ferdowsi, Farzad Shidfar, Iraj Heidari, Maryam Kashi, Mohammad Hassan Sohouli, Sara Sarrafi Zadeh. Effect of silymarin on lipid profile and glycemic control in patients with type 2 diabetes mellitus. Phytotherapy Research 2024; 38(9) doi: 10.1002/ptr.8273
|
| 9 |
Theerapon Tangsuwanaruk, Phantakan Tansuwannarat, Achara Tongpoo, Kanyapak Mirin, Satariya Trakulsrichai. Effect of oral silymarin in patients with acute hepatotoxic mushroom poisoning: an analysis of poison center data. Clinical Toxicology 2026; 64(2) doi: 10.1080/15563650.2025.2586098
|
| 10 |
Tony J. Fang, Jiun-Ting Guo, Ming-Kuem Lin, Meng-Shiou Lee, Yen-Lien Chen, Wen-Hsin Lin. Protective effects of Lactobacillus plantarum against chronic alcohol-induced liver injury in the murine model. Applied Microbiology and Biotechnology 2019; 103(20) doi: 10.1007/s00253-019-10122-8
|
| 11 |
Jiří Vrba, Barbora Papoušková, Kateřina Lněničková, Pavel Kosina, Vladimír Křen, Jitka Ulrichová. Identification of UDP-glucuronosyltransferases involved in the metabolism of silymarin flavonolignans. Journal of Pharmaceutical and Biomedical Analysis 2020; 178 doi: 10.1016/j.jpba.2019.112972
|
| 12 |
Chaoyue Yang, Mingli Zhong, Xuefei Jiao, Houkang Cao, Yandan Qin, Hengjie Xu, Fengyue Guo, Zixuan Tang, Tiansong Lv, Lilin Guan, Yongwang Wang, Ya Gao, Kefeng Zhang. Polysaccharides from Dicliptera chinensis (L.) Juss. Attenuates drug-induced liver injury by phosphorylating AMPK and thus facilitating the entry of FOXO3 into the cell nucleus. International Immunopharmacology 2025; 155 doi: 10.1016/j.intimp.2025.114633
|
| 13 |
Sandeep B. Subramanya, Balaji Venkataraman, Mohamed Fizur Nagoor Meeran, Sameer N. Goyal, Chandragouda R. Patil, Shreesh Ojha. Therapeutic Potential of Plants and Plant Derived Phytochemicals against Acetaminophen-Induced Liver Injury. International Journal of Molecular Sciences 2018; 19(12) doi: 10.3390/ijms19123776
|
| 14 |
Aisha Shabbir, Misbah Arshad, Ali Junaid Dar, Sidra Khalid. Pathophysiology and Diagnosis of Chronic Liver Disease. Pakistan Journal of Health Sciences 2021; doi: 10.54393/pjhs.v2i01.22
|
| 15 |
Sigrun Chrubasik-Hausmann. Mariendistel – Arzneipflanze des Jahres 2021 in Österreich. Zeitschrift für Komplementärmedizin 2021; 13(02) doi: 10.1055/a-1410-1576
|
| 16 |
Abbas Alimoradian, Masoume Garshasbi, Mohaddeseh Asafari, Mohammad Golitaleb, Reza Mansouri Tabar, Sepideh Mortaji khiabani, Reza Tajik. Effect of Silymarin on Hepatic Complications Caused by Methotrexate and its Analgesic Effects in Patients with Rheumatoid Arthritis. Scientific Journal of Kurdistan University of Medical Sciences 2023; 28(4) doi: 10.61186/sjku.28.4.95
|
| 17 |
Davis Kiprono Ngetich, Scolastica Korir. Liver biomarkers of silymarin milk thistle on paracetamol induced liver toxicity in adult albino rats (Rattus norvegicus). International Journal of Basic & Clinical Pharmacology 2025; 14(2) doi: 10.18203/2319-2003.ijbcp20250474
|
| 18 |
Jiyoon Lee, Jiyoung Park, Sang-Joon Lee, Changbaig Hyun. Evaluation of Hepatoprotectants in the Management of Subclinical Gallbladder Mucocele in Dogs. Animals 2025; 15(20) doi: 10.3390/ani15203002
|
| 19 |
Beom Kyung Kim. Metabolic Dysfunction‐Associated Steatotic Liver Disease and Obesity: Pathogenesis, Diagnostics, Risk Stratification, and Therapeutic Approach. The Kaohsiung Journal of Medical Sciences 2026; doi: 10.1002/kjm2.70227
|
| 20 |
Hossein Bahari, Mostafa Shahraki Jazinaki, Mohammad Rashidmayvan, Shaghayegh Taheri, Mohammad Reza Amini, Mahsa Malekahmadi. The effects of silymarin consumption on inflammation and oxidative stress in adults: a systematic review and meta-analysis. Inflammopharmacology 2024; 32(2) doi: 10.1007/s10787-023-01423-6
|
| 21 |
Zelma Faisal, Violetta Mohos, Eszter Fliszár-Nyúl, Kateřina Valentová, Kristýna Káňová, Beáta Lemli, Sándor Kunsági-Máté, Miklós Poór. Interaction of silymarin components and their sulfate metabolites with human serum albumin and cytochrome P450 (2C9, 2C19, 2D6, and 3A4) enzymes. Biomedicine & Pharmacotherapy 2021; 138 doi: 10.1016/j.biopha.2021.111459
|
| 22 |
Asad Izziddin Dajani, Adnan Abuhammour. Agents for the treatment of fatty liver disease: focus on essential phospholipids. Drugs & Therapy Perspectives 2021; 37(6) doi: 10.1007/s40267-021-00838-x
|
| 23 |
Tanya RALLI, Tusha TRIPATHI, Vivekanandan KALAISELVAN, Ritu TIWARI, Vidhu AERI, Kanchan KOHLI. Silymarin as a phyto-pharmaceutical: Isolation, simultaneous quantification of four biomarkers and in-silico anti-inflammatory activity. Chinese Journal of Analytical Chemistry 2023; 51(3) doi: 10.1016/j.cjac.2022.100174
|
| 24 |
Fedir V. Hladkykh, Tetiana I. Liadova, Serhii O. Soloviov. FEATURES OF THE CELL CYCLE OF HEPATOCYTES IN EXPERIMENTAL AUTOIMMUNE HEPATITIS ON THE BACKGROUND OF THE USE OF PLACENTA AND SPLEEN CRYOEXTRACTS, AS WELL AS THE CONDITIONED ENVIRONMENT OF MESENCHIMAL STEM CELLS. Clinical and Preventive Medicine 2024; (7) doi: 10.31612/2616-4868.7.2024.03
|
| 25 |
Gertrud-Alexandra PALTINEAN, Gheorghe TOMOAIA, Sorin RIGA, Aurora MOCANU, Maria TOMOAIA-COTISEL. Silymarin Based Complexes – a mini review. Annals of the Academy of Romanian Scientists Series on Biological Sciences 2022; 11(1) doi: 10.56082/annalsarscibio.2022.1.146
|
| 26 |
Saeed Badiei, Shima Rahmati, Hadi Raeisi Shahraki, Zahra Habibi. The Effect of Oral Silymarin on Remdesivir-Induced Hepatotoxicity and Clinical Course in Covid-19 Patients; A Double-Blind Randomized Controlled Trial. Journal of Occupational Health and Epidemiology 2023; 12(3) doi: 10.61186/johe.12.3.132
|
| 27 |
Mai M. Zahra, Elham H. A. Ali, Hend A. Sabry. Icariin is a potential neurodegenerative candidate against ammonia–glutamate excitotoxicity–oxidative stress pathway. The Journal of Basic and Applied Zoology 2024; 85(1) doi: 10.1186/s41936-024-00401-w
|
| 28 |
İbrahim Aktaş, İlkay Armağan. Investigation of the positive effects of silymarin on valproic acid-induced liver damage in rats. Adıyaman Üniversitesi Sağlık Bilimleri Dergisi 2019; 5(2) doi: 10.30569/adiyamansaglik.568226
|
| 29 |
Stavra A. Xanthakos, Samar H. Ibrahim, Kathryn Adams, Rohit Kohli, Pushpa Sathya, Shikha Sundaram, Miriam B. Vos, Ashish Dhawan, Sonia Caprio, Cynthia A. Behling, Jeffrey B. Schwimmer. AASLD Practice Statement on the evaluation and management of metabolic dysfunction–associated steatotic liver disease in children. Hepatology 2025; 82(5) doi: 10.1097/HEP.0000000000001368
|
| 30 |
İbrahim AKTAŞ, Murat SEVİMLİ. The Treatment Effect of Silymarin on Brain Damage in Rats. Van Veterinary Journal 2020; 31(2) doi: 10.36483/vanvetj.658220
|
| 31 |
M. A. Lieshchova, V. V. Brygadyrenko. Effect of Echinacea purpurea and Silybum marianum seeds on the body of rats with an excessive fat diet . Biosystems Diversity 2023; 31(1) doi: 10.15421/012310
|
| 32 |
Ying Kun Sheng, Lu Zhang, Yin Hong. Silymarin in Preventing Anti-Tuberculosis and Antipsychotic Drug-Induced Liver Injury at Different Doses and Treatment Times: A Systematic Review. Iranian Red Crescent Medical Journal 2019; 21(10) doi: 10.5812/ircmj.94743
|
| 33 |
Illia Koshurba, Mykola Chyzh, Fedir Hladkykh, Iryna Belochkina. Influence of Placenta Cryoextract on the Liver Metabolic and Functional State in Case of D-Galactosamine Hepatitis. Innovative Biosystems and Bioengineering 2022; 6(2) doi: 10.20535/ibb.2022.6.2.264774
|
| 34 |
Anirban Mandal, Banasri Hazra. Medicinal plant molecules against hepatitis C virus: Current status and future prospect. Phytotherapy Research 2023; 37(10) doi: 10.1002/ptr.7936
|
| 35 |
Marie Fenclova, Alena Novakova, Jitka Viktorova, Petra Jonatova, Zbynek Dzuman, Tomas Ruml, Vladimir Kren, Jana Hajslova, Libor Vitek, Milena Stranska-Zachariasova. Poor chemical and microbiological quality of the commercial milk thistle-based dietary supplements may account for their reported unsatisfactory and non-reproducible clinical outcomes. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-47250-0
|
| 36 |
Prarthana Sharma, Varun Asediya, Garima Kalra, Sharmin Sultana, Nihal Purohit, Kamila Kibitlewska, Wojciech Kozera, Urszula Czarnik, Krzysztof Karpiesiuk, Marek Lecewicz, Paweł Wysocki, Adam Lepczyński, Małgorzata Ożgo, Marta Marynowska, Agnieszka Herosimczyk, Elżbieta Redlarska, Brygida Ślaska, Krzysztof Kowal, Angelika Tkaczyk-Wlizło, Paweł Grychnik, Athul P. Kurian, Kaja Ziółkowska-Twarowska, Katarzyna Chałaśkiewicz, Katarzyna Kępka-Borkowska, Ewa Poławska, Magdalena Ogłuszka, Rafał R. Starzyński, Hiroaki Taniguchi, Chandra Shekhar Pareek, Mariusz Pierzchała. Hepatoprotective Effect of Silymarin Herb in Prevention of Liver Dysfunction Using Pig as Animal Model. Nutrients 2025; 17(20) doi: 10.3390/nu17203278
|
| 37 |
Václav Tvrdý, Maria Carmen Catapano, Tomasz Rawlik, Jana Karlíčková, David Biedermann, Vladimír Křen, Přemysl Mladěnka, Kateřina Valentová. Interaction of isolated silymarin flavonolignans with iron and copper. Journal of Inorganic Biochemistry 2018; 189 doi: 10.1016/j.jinorgbio.2018.09.006
|
| 38 |
Eduardo E. Vargas-Pozada, Pablo Muriel. Herbal medicines for the liver: from bench to bedside. European Journal of Gastroenterology & Hepatology 2020; 32(2) doi: 10.1097/MEG.0000000000001485
|
| 39 |
Francesca Casini, Francesca Scaltrito, Maria Teresa Grimaldi, Tudor Lucian Pop, Valeria Calcaterra, Gian Vincenzo Zuccotti, Massimo Pettoello-Mantovani, Pietro Ferrara, Giovanni Corsello, Valentina Fabiano. Use of complementary and alternative medicine in children affected by oncologic, neurologic and liver diseases: a narrative review. Italian Journal of Pediatrics 2023; 49(1) doi: 10.1186/s13052-023-01554-0
|
| 40 |
Muhmmad Nadeem Akhtar, Rabia Saeed, Farhan Saeed, Aasma Asghar, Samia Ghani, Huda Ateeq, Aftab Ahmed, Amara Rasheed, Muhammad Afzaal, Marwa Waheed, Bilal Hussain, Mohd Asif Shah. Silymarin: a review on paving the way towards promising pharmacological agent. International Journal of Food Properties 2023; 26(1) doi: 10.1080/10942912.2023.2244685
|
| 41 |
Rou Tang, Rui Li, He Li, Xiao-Lei Ma, Peng Du, Xiao-You Yu, Ling Ren, Lu-Lu Wang, Wen-Sheng Zheng. Design of Hepatic Targeted Drug Delivery Systems for Natural Products: Insights into Nomenclature Revision of Nonalcoholic Fatty Liver Disease. ACS Nano 2021; 15(11) doi: 10.1021/acsnano.1c02158
|
| 42 |
Meng Wang, Lei Zhang, Hao Yue, Weizhen Cai, Haowen Yin, Yingying Tian, Ping Dong, Jingfeng Wang. Peptides from Antarctic krill (Euphausia superba) ameliorate acute liver injury in mice induced by carbon tetrachloride via activating the Nrf2/HO-1 pathway. Food & Function 2023; 14(8) doi: 10.1039/D2FO03269D
|
| 43 |
Md Mortuza Hossain, Sung Bo Cho, In Ho Kim. Silybum marianum seed extract as a potential phytogenic feed additive for improving growth performance and nutrient digestibility in growing pigs. Canadian Journal of Animal Science 2024; 104(1) doi: 10.1139/cjas-2023-0053
|
| 44 |
Cyriac Abby Philips, Arif Hussain Theruvath, Resmi Ravindran, Philip Augustine. Complementary and alternative medicines and liver disease. Hepatology Communications 2024; 8(4) doi: 10.1097/HC9.0000000000000417
|
| 45 |
Zhu Wenbo, Han Jianwei, Liu Hua, Tang Lei, Chen Guijuan, Tian Mengfei. The potential of flavonoids in hepatic fibrosis: A comprehensive review. Phytomedicine 2024; 133 doi: 10.1016/j.phymed.2024.155932
|
| 46 |
Jin Hwa Song, Seo-Young Yoon, Tae Yun Park, Eun Young Heo, Deog Kyeom Kim, Hee Soon Chung, Jung-Kyu Lee. The clinical impact of drug-induced hepatotoxicity on anti-tuberculosis therapy: a case control study. Respiratory Research 2019; 20(1) doi: 10.1186/s12931-019-1256-y
|
| 47 |
Abdullah Saad Abdullah, Ibrahim El Tantawy El Sayed, Abdel Moneim A. El-Torgoman, Abul Kalam, S. Wageh, Maher A. Kamel. Green Synthesis of Silymarin–Chitosan Nanoparticles as a New Nano Formulation with Enhanced Anti-Fibrotic Effects against Liver Fibrosis. International Journal of Molecular Sciences 2022; 23(10) doi: 10.3390/ijms23105420
|
| 48 |
Fatemeh Mohtashaminia, Mohammad Reza Amini, Fatemeh Sheikhhossein, Kurosh Djafarian, Sakineh Shab-Bidar. Effects berberine–silymarin on liver enzymes: A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN 2022; 49 doi: 10.1016/j.clnesp.2022.01.037
|
| 49 |
Daniela Ciobârcă, Adriana Florinela Cătoi, Laura Gavrilaș, Roxana Banc, Doina Miere, Lorena Filip. Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease. Pharmaceuticals 2025; 18(2) doi: 10.3390/ph18020279
|
| 50 |
Yibai Xiong, Yan Ma, Yaxin Tian, Chi Zhang, Wei Yang, Bin Liu, Lianguo Ruan, Cheng Lu, Luqi Huang. A Longitudinal Cohort Study Using a Modified Child-Pugh Score to Escalate Respiratory Support in COVID-19 Patients — Hubei Province, China, 2020. China CDC Weekly 2021; 3(20) doi: 10.46234/ccdcw2021.113
|
| 51 |
Alka Singh, Gauree Kukreti, Shalu Verma, Kiran Dobhal. The Chemistry inside Spices & Herbs: Research and Development. 2024; doi: 10.2174/9789815196801124030006
|
| 52 |
Wenya Meng, Xinyi Huang, Long Xing, Jing Zhang, Ping Dong. Hepatoprotective activity of vitamin A and provitamin A purified from scallop (Azumapecten farreri) viscera waste using macroporous resin. Food Bioscience 2025; 65 doi: 10.1016/j.fbio.2025.106077
|
| 53 |
Manuela Grimstein, Shiew-Mei Huang. A regulatory science viewpoint on botanical–drug interactions. Journal of Food and Drug Analysis 2018; 26(2) doi: 10.1016/j.jfda.2018.01.013
|
| 54 |
Marie Fenclova, Milena Stranska-Zachariasova, Frantisek Benes, Alena Novakova, Petra Jonatova, Vladimir Kren, Libor Vitek, Jana Hajslova. Liquid chromatography–drift tube ion mobility–mass spectrometry as a new challenging tool for the separation and characterization of silymarin flavonolignans. Analytical and Bioanalytical Chemistry 2020; 412(4) doi: 10.1007/s00216-019-02274-3
|
| 55 |
Tingting Yan, Nana Yan, Ping Wang, Yangliu Xia, Haiping Hao, Guangji Wang, Frank J. Gonzalez. Herbal drug discovery for the treatment of nonalcoholic fatty liver disease. Acta Pharmaceutica Sinica B 2020; 10(1) doi: 10.1016/j.apsb.2019.11.017
|
| 56 |
Erhan Sahin, Ridvan Bagci, Nuriye Ezgi Bektur Aykanat, Sedat Kacar, Varol Sahinturk. Silymarin attenuated nonalcoholic fatty liver disease through the regulation of endoplasmic reticulum stress proteins GRP78 and XBP-1 in mice. Journal of Food Biochemistry 2020; 44(6) doi: 10.1111/jfbc.13194
|
| 57 |
Jitka Viktorova, Milena Stranska-Zachariasova, Marie Fenclova, Libor Vitek, Jana Hajslova, Vladimir Kren, Tomas Ruml. Complex Evaluation of Antioxidant Capacity of Milk Thistle Dietary Supplements. Antioxidants 2019; 8(8) doi: 10.3390/antiox8080317
|
| 58 |
Mihaela-Iustina Condurache, Anca-Roxana Petrovici, Natalia Simionescu, Bianca-Stefania Profire, Luminita-Georgeta Confederat, Alexandra Bujor, Anca Miron, Lenuta Profire. Simultaneous Determination of Glibenclamide and Silymarin Released from Chitosan Microparticles by HPLC-ESI-MS Technique: Method Development and Validation. Pharmaceutics 2022; 14(10) doi: 10.3390/pharmaceutics14102164
|
| 59 |
Colin G. Rousseaux. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 3. 2023; doi: 10.1016/B978-0-443-16153-7.00004-6
|
| 60 |
Rooshi Nathwani, Benjamin H. Mullish, David Kockerling, Roberta Forlano, Pinelopi Manousou, Ameet Dhar. A Review of Liver Fibrosis and Emerging Therapies. European Medical Journal 2020; doi: 10.33590/emj/10310892
|
| 61 |
Ziyue Zhang, Bozhi Shi, Xueze Lv, Yingchao Dong, Lei Li, Zhaofei Xia. Effects of silybin supplementation on growth performance, serum indexes and liver transcriptome of Peking ducks. Frontiers in Veterinary Science 2024; 10 doi: 10.3389/fvets.2023.1325115
|
| 62 |
Ankur Maity, Sayed Mohammed Firdous, Deep Pathak, Bijoy Paria. Unrevealing the Role of Flavonoids in Mitigation of Non-Alcoholic Fatty Liver Disease. Medicinal Chemistry Research 2026; doi: 10.1007/s00044-026-03564-z
|
| 63 |
Н.Н. Силивончик, Т.Н. Якубчик. Sylimarin: Traditional and New Effects. Рецепт 2021; (1) doi: 10.34883/PI.2021.24.1.003
|
| 64 |
Camila Ribeiro de Avelar, Beatriz Vieira Coelho Nunes, Betina da Silva Sassaki, Mariana dos Santos Vasconcelos, Lucivalda Pereira Magalhães de Oliveira, André Castro Lyra, Allain Amador Bueno, Rosângela Passos de Jesus. Efficacy of silymarin in patients with non-alcoholic fatty liver disease — the Siliver trial: a study protocol for a randomized controlled clinical trial. Trials 2023; 24(1) doi: 10.1186/s13063-023-07210-6
|
| 65 |
Shawky M. Aboelhadid, Saeed El-Ashram, Khaled M. Hassan, Waleed M Arafa, Ahmed BahaaEldin Darwish. Hepato-protective effect of curcumin and silymarin against Eimeria stiedae in experimentally infected rabbits. Livestock Science 2019; 221 doi: 10.1016/j.livsci.2019.01.011
|
| 66 |
Mohammad Mehdi Ommati, Omid Farshad, Negar Azarpira, Elmira Ghazanfari, Hossein Niknahad, Reza Heidari. Silymarin mitigates bile duct obstruction-induced cholemic nephropathy. Naunyn-Schmiedeberg's Archives of Pharmacology 2021; 394(6) doi: 10.1007/s00210-020-02040-8
|
| 67 |
Mina Mirnezami, Hadi Jafarimanesh, Masoud Rezagholizamenjany, Abbas Alimoradian, Mehdi Ranjbaran. The effect of silymarin on liver enzymes in patients taking isotretinoin: A randomized clinical trial. Dermatologic Therapy 2020; 33(2) doi: 10.1111/dth.13236
|
| 68 |
Shooka Mohammadi, Damoon Ashtary‐Larky, Omid Asbaghi, Vida Farrokhi, Yasaman Jadidi, Fatemeh Mofidi, Mehrnaz Mohammadian, Reza Afrisham. Effects of silymarin supplementation on liver and kidney functions: A systematic review and dose–response meta‐analysis. Phytotherapy Research 2024; 38(5) doi: 10.1002/ptr.8173
|
| 69 |
Kamila Bechynska, Vit Kosek, Marie Fenclova, Lucie Muchova, Vaclav Smid, Jakub Suk, Karel Chalupsky, Eva Sticova, Kamila Hurkova, Jana Hajslova, Libor Vitek, Milena Stranska. The Effect of Mycotoxins and Silymarin on Liver Lipidome of Mice with Non-Alcoholic Fatty Liver Disease. Biomolecules 2021; 11(11) doi: 10.3390/biom11111723
|
| 70 |
O. V. Ketsa, I. Y. Kapitanchuk. Biochemical markers of hepatobiliary system functional state in rats under the action of laser irradiation and ω-3 polyunsaturated fatty acids. The Animal Biology 2021; 23(4) doi: 10.15407/animbiol23.04.043
|
| 71 |
Jakub Šuk, Jana Jašprová, David Biedermann, Lucie Petrásková, Kateřina Valentová, Vladimír Křen, Lucie Muchová, Libor Vítek. Isolated Silymarin Flavonoids Increase Systemic and Hepatic Bilirubin Concentrations and Lower Lipoperoxidation in Mice. Oxidative Medicine and Cellular Longevity 2019; 2019 doi: 10.1155/2019/6026902
|
| 72 |
Ludovico Abenavoli, Angelo A. Izzo, Natasa Milić, Carla Cicala, Antonello Santini, Raffaele Capasso. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytotherapy Research 2018; 32(11) doi: 10.1002/ptr.6171
|
| 73 |
Mahboobeh Zare, Malihe Norouzi Sarkati. Chitosan‐functionalized Fe3O4 nanoparticles as an excellent biocompatible nanocarrier for silymarin delivery. Polymers for Advanced Technologies 2021; 32(10) doi: 10.1002/pat.5416
|
| 74 |
Jemin Kim, Yun Na Lee, Joohee Lee, Sang Gyu Lee, Hyun Kim, Ye Seul Choi, Zoe Diana Draelos, Jihee Kim. Efficacy and safety of silymarin containing antioxidant serum as an adjuvant treatment of mild‐to‐moderate acne vulgaris: A prospective, open‐label pilot study. Journal of Cosmetic Dermatology 2023; 22(2) doi: 10.1111/jocd.15439
|
| 75 |
Anton Gillessen, Francesco Angelico, Jun Chen, Lungen Lu, Maria Isabel Lucena, Qingchun Fu, Qing Xie, Raul J. Andrade, Wen Xie, Xiaoyuan Xu, Yanyan Yu, Yi-min Mao, Yuemin Nan. Silymarin for Treating Toxic Liver Disease: International Consensus Recommendations. Gastro Hep Advances 2022; 1(5) doi: 10.1016/j.gastha.2022.05.006
|
| 76 |
F.V. Hladkykh, Т.І. Liadova. Characteristics of the hepatotropic activity of cell-free cryopreserved biological agents in the model of autoimmune hepatitis. The Journal of V. N. Karazin Kharkiv National University, Series "Medicine" 2024; (50) doi: 10.26565/2313-6693-2024-50-01
|
| 77 |
Michael J Carbonell, Madeleine Graydon, Saliha Mahmood, Heather Lewis, Ameet Dhar, Benjamin H Mullish, Luke D Tyson. A practical approach to nutrition in people with cirrhosis. Frontline Gastroenterology 2025; doi: 10.1136/flgastro-2025-103201
|
| 78 |
Hafiza Madiha Jaffar, Fahad Al‐Asmari, Faima Atta Khan, Muhammad Abdul Rahim, Eliasse Zongo. Silymarin: Unveiling its pharmacological spectrum and therapeutic potential in liver diseases—A comprehensive narrative review. Food Science & Nutrition 2024; 12(5) doi: 10.1002/fsn3.4010
|
| 79 |
|
| 80 |
Laurent Mailly, Thomas F. Baumert. Hepatitis C virus infection and tight junction proteins: The ties that bind. Biochimica et Biophysica Acta (BBA) - Biomembranes 2020; 1862(7) doi: 10.1016/j.bbamem.2020.183296
|
| 81 |
Tiziano Balzano, Marta Llansola, Yaiza M. Arenas, Paula Izquierdo-Altarejos, Vicente Felipo. Hepatic encephalopathy: investigational drugs in preclinical and early phase development. Expert Opinion on Investigational Drugs 2023; 32(11) doi: 10.1080/13543784.2023.2277386
|
| 82 |
Xiqiao Wang, Bo Yuan. Jaundice Occurrence After a Large Area Burn Is a Possible Indication to Delay Surgery. Journal of Burn Care & Research 2020; 41(3) doi: 10.1093/jbcr/irz206
|
| 83 |
Jing Wang, Na Yang, Yu Xu. Natural Products in the Modulation of Farnesoid X Receptor Against Nonalcoholic Fatty Liver Disease. The American Journal of Chinese Medicine 2024; 52(02) doi: 10.1142/S0192415X24500137
|
| 84 |
Neti Jayanti, Rozzana Said, Suhaidah Jofrry, Chee-Yan Choo. Mechanistic pathway of herbs in the amelioration of NAFLD: A systematic review. World Academy of Sciences Journal 2024; 6(4) doi: 10.3892/wasj.2024.245
|
| 85 |
Bi-xi Tang, Yong Zhang, Dan-dan Sun, Qin-yi Liu, Cong Li, Pei-pei Wang, Li-xin Gao, Xue-mei Zhang, Jia Li, Wei-liang Zhu, Yi Zang. Luteolin-7-diglucuronide, a novel PTP1B inhibitor, ameliorates hepatic stellate cell activation and liver fibrosis in mice. Acta Pharmacologica Sinica 2025; 46(1) doi: 10.1038/s41401-024-01351-3
|
| 86 |
Sean P. Tighe, Daud Akhtar, Umair Iqbal, Aijaz Ahmed. Chronic Liver Disease and Silymarin: A Biochemical and Clinical Review. Journal of Clinical and Translational Hepatology 2020; 8(4) doi: 10.14218/JCTH.2020.00012
|
| 87 |
Moloud Fakhri, Hafez Fakheri, Mohammad Azadbakht, Mahmood Moosazadeh, Seyde Sedighe Yousefi. Effect of Medicinal Plants and Natural Products on Liver Enzymes in Non-alcoholic Fatty Liver Patients in Iran: A Systematic Review and Meta-Analysis. International Journal of Preventive Medicine 2022; 13(1) doi: 10.4103/ijpvm.IJPVM_313_20
|